Where it is registered
Each register with its number of medicines and a few of them.
Saudi Arabia
SFDA · 1 medicine · Historical list
All medicines with Meningococcal group b
Every register, a page at a time. Strengths and packs are on each medicine’s page.
23 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Bexsero | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| PenmenvyCombination | United States | 25UG/0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Trumenba | United States | 0.5ML | Injection | Marketed | Wyeth Pharmaceuticals LLC |
| PenbrayaCombination | United States | 5UG | Injection | Marketed | Pfizer Ireland Pharmaceuticals Unlimited Company |
| TrumenbaCombination | Saudi Arabia | Authorised | Pfizer | ||
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenactraCombination | United States | 48UG/.5ML | For Injection | Marketed | Sanofi Vaccines US Inc. |
| Menquadfi | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| Bexsero | European Union | Authorised | GSK Vaccines S.r.l. | ||
| Trumenba | European Union | Authorised | Pfizer Europe MA EEIG | ||
| MenhibrixCombination | United States | 0.5ML | Injection | Withdrawn | GlaxoSmithKline Biologicals |
| NimenrixCombination | Canada | 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 44 MCG / 0.5 ML | Kit, Powder For Solution | Marketed | Pfizer Canada Ulc |
| MenQuadfiCombination | New Zealand | Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| NimenrixCombination | New Zealand | Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| MeningitecCombination | Canada | 15 MCG / 0.5 ML + 10 MCG / 0.5 ML | Suspension | Cancelled | Nuron Biotech B.V. |
| NimenrixCombination | Saudi Arabia | Authorised | Pfizer Manufacturing Belgium N.V. | ||
| MenomuneCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Menomune-A | United States | 0.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Menomune-C | United States | 0.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Penbraya | European Union | Withdrawn | Pfizer Europe MA EEIG | ||
| Menomune-A/CCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Menomune-A/CCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1